BeiGene to build late-stage clinical and commercial production capacity for cancer monoclonal antibodies with GE Healthcare’s KUBio, the prefabricated biopharma facility based on single-use technologies CHALFONT ST. GILES, UK and BEIJING, CHINA – 18 September 2018 – BeiGene, Ltd., a commercial
https://www.ge.com/news/press-releases/beigene-selects-ge-healthcares-shelf-biologics-factory-boost-its-manufacturing